Optimising workflows
We provide solutions for customers working across cell line development:
Novel Biotherapeutics
Isolate, screen and characterise attributes for clones producing novel recombinant proteins e.g. monoclonal antibodies or therapeutic proteins for rare diseases
Biosimilars and Biobetters
Generate stable cell lines to create equivalents (Biosimilars) or improved versions (Biobetters) of existing blockbuster therapeutic antibodies for which the patent has, or will shortly, expire
Gene Therapy
Develop new, stable, producer cell lines manufacturing viruses to subsequently infect target cells of patients
Gene Editing & Cell Engineering
Optimise your drug discovery process using targeted gene editing to create stable cell lines as cellular reagents, for use in target validation, functional genomics and disease modelling
VIEW OUR WEBINAR
"How a Top-5 Pharma Doubled the Speed of Cell Line Development"
Latest News
Viral Production for Gene Therapy
Moving towards clinical grade production In the latest edition of this Podcast series, Duncan Borthwick speaks to Mark Stockdale about the developing regulatory landscape around viral production for clinical gene
Cell Line Development – A look at the evolution, new advances and future developments of this critical process step
In a recent interview with Cell Culture Dish, Dr Ian Taylor discusses the evolution of cell line development, new advances in technologies and workflows, and future advances. The discussion includes
Podcast | Planning a CLD Lab
Workflows, Clonality Assurance and New Tech Following the postponement of the BioProcess International (BPI) US West Conference, Santa Clara in March 2020, Duncan Borthwick speaks to Mark Stockdale about the
Solentim names Mark Truesdale as new CEO
Dr Mark Truesdale Bournemouth, UK, 2nd March 2020 / Sciad Newswire / Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed
Join Solentim, along with leading European cell line development innovators, at Bioprocessing Summit Europe 2020
Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be exhibiting at the 3rd annual Bioprocessing Summit Europe, taking place 24-26 March 2020 in
Join Solentim in meeting Europe’s leading innovators at Biologics World Nordic
Nordic region comes out top in the annual European Innovation Scoreboard (EIS) which provides a comparative assessment of research and innovation performance across the EU Life